Highlights•Different studies related to improve probiotic formulations are
described.•Potential sources of probiotics have been discussed to help researchers.•Health …

Inflammatory bowel diseases (IBD), including Crohn's disease, ulcerative colitis, and
pouchitis, are chronic, relapsing intestinal inflammatory disorders mediated by dysregulated …

Introduction Clinicians and patients face a daunting task when choosing the most
appropriate probiotic for their specific needs. Available preparations encompass a diverse …

Current treatments for intestinal diseases including inflammatory bowel diseases, irritable
bowel syndrome, and colonic bacterial infections are typically small molecule oral dosage …

The intestine barrier, the front line of normal body defense, relies on its structural integrity,
microbial composition and barrier immunity. The intestinal mucosal surface is continuously …

Medical care for patients hospitalized with COVID-19 is an evolving process. Most COVID-
19 inpatients (58–95%) received empiric antibiotics to prevent the increased mortality due to …

Lactobacillus paracasei K5 is a lactic acid bacteria (LAB) strain, isolated recently from feta-
type cheese. Its probiotic potential has been demonstrated in a series of established in vitro …

Opportunistic pathogenic bacteria may cause disease after the normally protective
microbiome is disrupted (typically by antibiotic exposure). Clostridioides difficile is one such …

The benefits of probiotics on dysbiotic microbiomes and inflammation are dependent on the
tested strain, host factors, and the resident microbiome. There is limited knowledge on the …

Bifidobacterium breve (YH68) is widely used in the fields of food fermentation and
biomedicine. In this study, we explored the antibacterial activity of the cell free culture …